Najafi Atabak, Emami Sara, Khajavi Mohammadreza, Etezadi Farhad, Imani Farsad, Lajevardi Mahbod, Pourfakhr Pejman, Moharari Reza Shariat
Department of Anesthesiology, Tehran University of Medical Sciences, Tehran, Iran.
Department of Anesthesiology, Tehran University of Medical Sciences, Tehran, Iran.
Acta Anaesthesiol Taiwan. 2014 Sep;52(3):95-100. doi: 10.1016/j.aat.2014.07.001. Epub 2014 Sep 8.
Postdural puncture headache (PDPH) is one of the common complications of spinal anesthesia; it is observed in 1-40% of cases involving spinal anesthesia. It can cause considerable morbidity and 40% of cases may require invasive treatments such as epidural blood patch. With the exception of invasive treatments such as an epidural blood patch, current standard treatment modalities have not proved efficacious. There had been some research done that indicated successful prophylaxis and/or treatment of PDPH by administration of intravenous steroids. Based on those findings, we hypothesize that a direct injection of corticosteroids to the anesthesia puncture site could increase the amount of corticosteroid that accumulates in the puncture site, and will be more effective in decreasing dural inflammation and incidence of PDPH than that of parenteral steroids. We formulated our study to evaluate the effect of dexamethasone directly injected into spinal anesthesia puncture sites.
A total of 268 patients undergoing spinal anesthesia were randomly allocated into two groups; one group received a prophylactic epidural injection of dexamethasone (2 mL, 8 mg) and the other group received 2 mL of normal saline. The incidence and intensity of PDPH and puncture site backache were each measured at 24 hours, 72 hours, and 7 days after spinal anesthesia. The intensity of the headache was graded according to the meningeal headache index.
The overall incidence of headache during the 7-day period was 5 patients (3.7%) in the control group and 11 patients (8.2%) in the study group, which is not statistically significant (X(2) = 2.393 and p = 0.122. The severity of headache also shows no statistical significance (2.2% in cases versus 6% in controls; z = 1.53, p = 0.126). The intensity of headache reported at the 24 hours (z = 0.698; p = 0.485), 72 hours (z = 0.849; p = 0.396), and 7 days (z = 0.008; p = 0.994) was not different. There also was no difference in the incidence of backache in the two groups.
In contrast to other studies that showed the efficacy of intravenous dexamethasone in the prevention and treatment of PDPH, our study did not show any significant effect of prophylactic epidural injection of dexamethasone in prevention of PDPH. However regarding the low number of PDPH in routine cases, evaluation of this intervention in groups with a high incidence of PDPH by using of particulate steroids is recommended to confirm these preliminary findings.
硬膜穿刺后头痛(PDPH)是脊髓麻醉常见的并发症之一;在1%-40%的脊髓麻醉病例中可观察到。它可导致相当大的发病率,40%的病例可能需要进行诸如硬膜外血贴等侵入性治疗。除了硬膜外血贴等侵入性治疗外,目前的标准治疗方式尚未证明有效。已有一些研究表明静脉注射类固醇可成功预防和/或治疗PDPH。基于这些发现,我们推测直接将皮质类固醇注射到麻醉穿刺部位可增加在穿刺部位积聚的皮质类固醇量,并且在减轻硬脊膜炎症和降低PDPH发病率方面比胃肠外给予类固醇更有效。我们制定本研究以评估直接注射地塞米松到脊髓麻醉穿刺部位的效果。
总共268例接受脊髓麻醉的患者被随机分为两组;一组接受预防性硬膜外注射地塞米松(2 mL,8 mg),另一组接受2 mL生理盐水。在脊髓麻醉后24小时、72小时和7天分别测量PDPH的发病率和强度以及穿刺部位背痛情况。头痛强度根据脑膜头痛指数进行分级。
7天期间头痛的总体发病率在对照组为5例患者(3.7%),在研究组为11例患者(8.2%),差异无统计学意义(X(2)=2.393,p=0.122)。头痛严重程度也无统计学意义(病例组为2.2%,对照组为6%;z=1.53,p=0.126)。在24小时(z=0.698;p=0.485)、72小时(z=0.849;p=0.396)和7天(z=0.008;p=0.994)报告的头痛强度无差异。两组背痛的发病率也无差异。
与其他显示静脉注射地塞米松在预防和治疗PDPH方面有效的研究不同,我们的研究未显示预防性硬膜外注射地塞米松在预防PDPH方面有任何显著效果。然而,鉴于常规病例中PDPH的数量较少,建议通过使用颗粒状类固醇在PDPH高发组中评估这种干预措施以证实这些初步发现。